ATE3774T1 - Beclomethason-ester-solvate, verfahren zu ihrer herstellung und herstellung einer formulierung. - Google Patents
Beclomethason-ester-solvate, verfahren zu ihrer herstellung und herstellung einer formulierung.Info
- Publication number
- ATE3774T1 ATE3774T1 AT80102385T AT80102385T ATE3774T1 AT E3774 T1 ATE3774 T1 AT E3774T1 AT 80102385 T AT80102385 T AT 80102385T AT 80102385 T AT80102385 T AT 80102385T AT E3774 T1 ATE3774 T1 AT E3774T1
- Authority
- AT
- Austria
- Prior art keywords
- preparation
- formulation
- beclomethasone
- beclomethasone ester
- solvate
- Prior art date
Links
- 239000012453 solvate Substances 0.000 title abstract 4
- 229940092705 beclomethasone Drugs 0.000 title abstract 3
- -1 BECLOMETHASONE ESTER Chemical class 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000001335 aliphatic alkanes Chemical class 0.000 abstract 2
- NBMKJKDGKREAPL-DVTGEIKXSA-N beclomethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O NBMKJKDGKREAPL-DVTGEIKXSA-N 0.000 abstract 2
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 abstract 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 abstract 1
- 229950000210 beclometasone dipropionate Drugs 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 229940029284 trichlorofluoromethane Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP80102385A EP0039369B1 (de) | 1980-05-02 | 1980-05-02 | Beclomethason-ester-solvate, Verfahren zu ihrer Herstellung und Herstellung einer Formulierung |
| AU58107/80A AU533551B2 (en) | 1980-05-02 | 1980-05-06 | Beclomethasone eser solvates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE3774T1 true ATE3774T1 (de) | 1983-06-15 |
Family
ID=25631966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT80102385T ATE3774T1 (de) | 1980-05-02 | 1980-05-02 | Beclomethason-ester-solvate, verfahren zu ihrer herstellung und herstellung einer formulierung. |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0039369B1 (de) |
| AT (1) | ATE3774T1 (de) |
| AU (1) | AU533551B2 (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR890000664B1 (ko) * | 1981-10-19 | 1989-03-22 | 바리 안소니 뉴우샘 | 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법 |
| KR880001237B1 (ko) * | 1984-07-25 | 1988-07-12 | 호비온 인터 리미티드 | 베클로메타손 17,21-디프로피오네이트의 용매화합물의 제조방법 |
| GB8432063D0 (en) * | 1984-12-19 | 1985-01-30 | Riker Laboratories Inc | Physically modified steroids |
| US7105152B1 (en) | 1991-12-18 | 2006-09-12 | 3M Innovative Properties Company | Suspension aerosol formulations |
| DK0617610T3 (da) | 1991-12-18 | 1997-10-06 | Minnesota Mining & Mfg | Suspensionsaerosolformuleringer. |
| US7101534B1 (en) | 1991-12-18 | 2006-09-05 | 3M Innovative Properties Company | Suspension aerosol formulations |
| MX9304585A (es) | 1992-07-31 | 1994-03-31 | Glaxo Group Ltd | Formulacion farmaceutica en aerosol, lata adecuada para liberar la formulacion e inhalador de dosis dosificada que comprende la lata. |
| DE4433374A1 (de) * | 1994-09-20 | 1996-03-21 | Hoechst Ag | 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
| US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
| US20070122353A1 (en) | 2001-05-24 | 2007-05-31 | Hale Ron L | Drug condensation aerosols and kits |
| US7090830B2 (en) | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
| CA2446904A1 (en) | 2001-05-24 | 2003-04-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
| WO2003026631A1 (en) * | 2001-05-24 | 2003-04-03 | Alexza Molecular Delivery Corporation | Delivery of drug esters through an inhalation route |
| US20030051728A1 (en) | 2001-06-05 | 2003-03-20 | Lloyd Peter M. | Method and device for delivering a physiologically active compound |
| US7645442B2 (en) | 2001-05-24 | 2010-01-12 | Alexza Pharmaceuticals, Inc. | Rapid-heating drug delivery article and method of use |
| US7585493B2 (en) | 2001-05-24 | 2009-09-08 | Alexza Pharmaceuticals, Inc. | Thin-film drug delivery article and method of use |
| GB0208742D0 (en) | 2002-04-17 | 2002-05-29 | Bradford Particle Design Ltd | Particulate materials |
| US7582284B2 (en) | 2002-04-17 | 2009-09-01 | Nektar Therapeutics | Particulate materials |
| US7913688B2 (en) | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
| JP2007516149A (ja) | 2003-05-21 | 2007-06-21 | アレックザ ファーマシューティカルズ， インコーポレイテッド | 基板温度の均一性を制御する方法、および、内蔵式加熱ユニットおよびそれを使用する薬剤供給ユニット |
| US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
| CA2576961A1 (en) | 2004-08-12 | 2006-03-02 | Alexza Pharmaceuticals, Inc. | Aerosol drug delivery device incorporating percussively activated heat packages |
| PT2425820E (pt) | 2007-02-11 | 2015-08-04 | Map Pharmaceuticals Inc | Método de administração terapêutica de dhe para permitir o rápido alívio das enxaquecas ao mesmo tempo que minimiza o perfil de efeitos secundários |
| EP2121088B1 (de) | 2007-03-09 | 2016-07-13 | Alexza Pharmaceuticals, Inc. | Erhitzungseinheit zur verwendung in einer arzneimittelabgabevorrichtung |
| GB0914240D0 (en) * | 2009-08-14 | 2009-09-30 | Breath Ltd | Steroid solvates |
| US12214118B2 (en) | 2018-02-02 | 2025-02-04 | Alexza Pharmaceuticals, Inc. | Electrical condensation aerosol device |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1429184A (en) * | 1972-04-20 | 1976-03-24 | Allen & Hanburys Ltd | Physically anti-inflammatory steroids for use in aerosols |
| MX3864E (es) * | 1975-05-27 | 1981-08-26 | Syntex Corp | Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona |
-
1980
- 1980-05-02 AT AT80102385T patent/ATE3774T1/de not_active IP Right Cessation
- 1980-05-02 EP EP80102385A patent/EP0039369B1/de not_active Expired
- 1980-05-06 AU AU58107/80A patent/AU533551B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0039369B1 (de) | 1983-06-15 |
| EP0039369A1 (de) | 1981-11-11 |
| AU5810780A (en) | 1981-11-19 |
| AU533551B2 (en) | 1983-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE3774T1 (de) | Beclomethason-ester-solvate, verfahren zu ihrer herstellung und herstellung einer formulierung. | |
| AT372277B (de) | Zahnreinigungsmittelzusammensetzung und verfahren zu deren herstellung | |
| ATE8790T1 (de) | Aromatische heterocyclische steroidester, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten. | |
| ATA430677A (de) | Verfahren zur herstellung von pharmazeutischen zusammensetzungen | |
| ATE1241T1 (de) | Verfahren zur herstellung von 4,5-perfluor-1,3-dioxolanen. | |
| ATA907180A (de) | Verfahren zur herstellung einer topischen benzoylperoxidzusammensetzung | |
| AT368729B (de) | Verfahren zur herstellung einer gewindeschneidschraube und nach dem verfahren hergestellte gewindeschneidschraube | |
| DD131019A5 (de) | Verfahren zur herstellung eines 2-desoxystreptaminaminoglycosides | |
| AT367295B (de) | Verfahren zur herstellung von pharmazeutischen zusammensetzungen | |
| ATE489T1 (de) | Sila-substituierte 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung, arzneimittel und verfahren zu deren herstellung. | |
| AT387032B (de) | Verfahren zur herstellung von in spruehgetrockneten reinigungsmitteln verwendbaren zeolith-alkylbenzolsulfonatzusammensetzungen mit hohem feststoffgehalt | |
| ATA541377A (de) | Verfahren zur herstellung einer pharmazeutischen zusammensetzung | |
| AR241108A2 (es) | Insecticidas piretroides, acidos ciclopropancarboxilicos y esteres intermediarios y sus precedimientos de preparacion | |
| IL57215A0 (en) | Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof and pharmaceutical compositions containing them | |
| PT69999A (de) | 1,2,3-triazolcarbonsaureamide verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel | |
| ATA814276A (de) | Verfahren zur herstellung des neuen 2,6- dimethyl-3-metoxycarbonyl-4-(2'-nitrophenyl)- 1,4-dihydropyridin-5-carbonsaeureisobutylesters | |
| DD137352A5 (de) | Verfahren zur herstellung von n hoch 2-arylsulfonyl-l-argininamiden und ihrer pharmaz5utisch vertraeglichen salze | |
| DD136832A5 (de) | Verfahren zur herstellung von 1,2-dichloraethan | |
| ATA63776A (de) | Verfahren zur herstellung von 1,2-benzisothiazolen | |
| AT379167B (de) | Verfahren zur herstellung einer aerosolzusammensetzung | |
| SE7806947L (sv) | Forfarande for framstellning av 2,2-dimetyl-5-(2,5-xylyloxi)valeriansyra | |
| DD135497A5 (de) | Verfahren zur herstellung von 17 beta hydroxy-4-androsten-3-onen | |
| DD134769A1 (de) | Verfahren zur herstellung von 3-oxo-oestra-4,9,11-trienen | |
| ATA707476A (de) | Verfahren zur herstellung von 2,4-dioxo- oxazoldinen | |
| ATA128180A (de) | Verfahren zur herstellung einer verarbeitungsfertigen lagerbestaendigen feuerfesten weitgehend geruchsfreien masse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |